Over the counter NSAIDs have consistently shown antitumor effects in animal models of carcinogenesis [21], and in recent studies, striking antitumor effects of the specific COX-2 inhibitor, celecoxib, have been observed against breast cancer [22]. Here, PTGS2 is linked to breast carcinoma.